T-CELL LEUKEMIA/LYMPHOMA, ADULT
Clinical trials for T-CELL LEUKEMIA/LYMPHOMA, ADULT explained in plain language.
Never miss a new study
Get alerted when new T-CELL LEUKEMIA/LYMPHOMA, ADULT trials appear
Sign up with your email to follow new studies for T-CELL LEUKEMIA/LYMPHOMA, ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to stop rare leukemia before it starts
Prevention Recruiting nowThis study tests whether the drug mogamulizumab can prevent adult T-cell leukemia/lymphoma (ATL) in people infected with HTLV-1 who are at higher risk due to changes in their T-cells. About 134 participants will receive a limited course of the drug to see if it reduces the virus …
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated May 20, 2026 11:58 UTC
-
Scientists target cancer Cells' weakness in new trial
Knowledge-focused Recruiting nowThis study looks for better ways to treat T-cell leukemia and lymphoma, a type of blood cancer. Researchers will test combinations of drugs that attack cancer cells by changing their internal balance of reactive oxygen species (ROS). The goal is to find which drug combinations wo…
Matched conditions: T-CELL LEUKEMIA/LYMPHOMA, ADULT
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated May 26, 2026 04:17 UTC